glp 1 news Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity As interest in GLP-1 medication

Competitive Landscape The India GLP-1 Receptor Agonist Market is dominated by several key players, reflecting a mix of local and global entities

In addition, GLP-1-specific tailored treatment is just around the corner

3h,i and Extended Data Fig

Association of GLP-1 receptor agonists with risk of suicidal ideation and behaviour: a systematic review and meta-analysis

Alzheimers Disease/ Type 3 Diabetes Research findings have found that the causes and long-term effects of poorly controlled Type 2 diabetes may indeed be directly affecting the cognitive decline associated with Alzheimers Disease

A newly released study that compared the weight loss and side effects experienced by 358 adults 65 and older who participated in trials of the drug semaglutide, or Wegovy, confirmed that seniors lost 15.5% of their body weight on average, while younger adults lost 15.6%, nearly exactly the same